Tela Bio Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | 5.2 | 5.6 | 9.3 | 13.7 | 11.9 | 10.6 | 9.5 | 7.4 | 6.3 | 5.3 | 2.9 | 3.7 | 5.3 | 4.5 | 4.8 | 3.7 | 2.8 | 2.2 | 1.8 | 0.9 | 1.7 | 0.8 | 1.1 | 0.9 | 0.8 | 0.4 | 0.5 | |
| – | – | – | – | – | – | – | 2.6 | 3.7 | 2.3 | 4.2 | 4.4 | 5.2 | 6.7 | 7.2 | 9.2 | 16.8 | – | 6.1 | 15.4 | 64.7 | 5.9 | 6.4 | 8.6 | 9.7 | 40.4 | – | 4.2 | 3.0 | 9.4 | 43.8 | 9.8 | – | – | |
| – | – | – | – | – | – | – | 4.2 | 4.9 | 5.8 | 10.8 | 9.5 | 8.9 | 8.3 | 6.6 | 5.9 | 5.3 | 3.3 | 3.4 | 5.3 | 4.7 | 4.3 | 3.4 | 2.7 | 2.3 | 2.0 | 1.3 | 1.6 | 0.7 | 1.2 | 1.0 | 0.8 | 0.6 | 0.9 | |
| – | – | – | – | – | – | – | -35.4% | -30.6% | -19.1% | -10.4% | -11.4% | -12.0% | -10.8% | -14.3% | -16.7% | -19.7% | -38.7% | -28.4% | -19.3% | -21.4% | -18.4% | -21.6% | -25.7% | -31.7% | -38.0% | -74.6% | -35.4% | -69.3% | -40.2% | -46.2% | -46.2% | -85.1% | -73.4% | |
| Margins | ||||||||||||||||||||||||||||||||||
| – | – | – | 43.2% | 49.0% | 54.2% | 56.4% | 60.0% | 61.0% | 61.3% | 60.5% | 61.7% | 61.4% | 63.5% | 62.8% | 63.9% | 64.0% | 62.9% | 64.3% | 65.3% | 66.4% | 68.3% | 69.1% | 68.6% | 69.0% | 68.6% | 68.3% | 67.1% | 66.9% | 67.3% | 67.2% | 67.7% | 67.3% | 67.8% | |
| – | – | – | -214.9% | -185.2% | -155.6% | -144.8% | -124.1% | -129.1% | -132.8% | -139.9% | -138.8% | -127.9% | -115.5% | -106.7% | -100.0% | -100.7% | -100.8% | -97.5% | -94.2% | -89.6% | -82.4% | -77.7% | -75.4% | -59.6% | -60.0% | -55.4% | -49.2% | -55.8% | -49.5% | -46.0% | -42.0% | -41.8% | -42.6% | |
| – | – | – | -315.1% | -231.6% | -190.5% | -179.0% | -145.2% | -149.2% | -152.5% | -158.2% | -158.1% | -145.9% | -130.6% | -121.3% | -112.9% | -113.2% | -116.8% | -112.5% | -106.9% | -100.8% | -88.5% | -82.4% | -79.8% | -63.8% | -65.0% | -60.5% | -54.6% | -61.0% | -54.1% | -50.6% | -48.4% | -49.3% | -51.5% | |
| – | – | – | -259.7% | -249.6% | -215.0% | -217.4% | -182.7% | -171.9% | -176.8% | -141.9% | -135.2% | -127.0% | -102.9% | -105.9% | -105.4% | -104.4% | -113.8% | -106.0% | -102.9% | -96.6% | -87.6% | -79.6% | -70.9% | -70.4% | -68.0% | -67.1% | -61.4% | -52.9% | -46.0% | -40.9% | -35.7% | -37.4% | -39.6% | |
| Returns | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | -72.4% | -97.7% | -38.6% | -48.9% | -58.7% | -71.3% | -91.2% | -117.0% | -165.6% | -358.7% | – | -184.3% | -309.7% | -1,447.3% | -108.8% | -143.2% | -247.1% | -280.2% | -1,467.2% | – | -133.0% | -239.7% | -443.9% | -2,504.7% | -615.1% | – | – | |
| – | – | – | -95.7% | -84.9% | -74.1% | -101.0% | -33.0% | -40.2% | -25.1% | -29.8% | -33.3% | -37.9% | -43.2% | -47.2% | -53.2% | -65.0% | -78.9% | -54.0% | -65.3% | -77.3% | -46.1% | -50.1% | -59.8% | -56.1% | -69.9% | -78.3% | -43.3% | -56.2% | -60.4% | -63.3% | -47.7% | -57.0% | -68.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||
| – | – | 12 | 12 | 47 | 12 | 19 | -15 | -11 | -55 | -51 | -44 | -35 | -29 | -22 | -12 | -1.0 | 12 | -14 | -1.8 | 10 | -25 | -17 | -5.6 | 4.1 | 15 | 24 | -11 | -1.0 | 6.9 | 12 | 4.8 | 17 | 26 | |
| – | – | -506.3% | -506.3% | -51.5% | -30.1% | -695.9% | 45.6% | 41.2% | 65.0% | 61.0% | 56.7% | 53.2% | 47.4% | 40.3% | 32.1% | 18.1% | -3.0% | 29.3% | 21.1% | 5.3% | 42.4% | 35.0% | 24.2% | 20.0% | 4.8% | -11.8% | 32.6% | 23.5% | 13.6% | 2.5% | 7.8% | -7.4% | -26.6% | |
| – | – | – | – | – | – | – | 1.0 | 1.3 | 0.5 | 0.5 | 0.6 | 0.7 | 0.9 | 1.1 | 1.6 | 3.2 | – | 1.7 | 2.8 | 12.9 | 1.0 | 1.3 | 2.2 | 2.9 | 14.4 | – | 1.5 | 2.3 | 4.6 | 27.0 | 8.8 | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||
| – | – | – | -4.02 | -3.49 | -3.30 | -2.19 | -3.66 | -2.08 | -2.14 | -1.91 | -2.00 | -2.06 | -2.21 | -2.24 | -2.29 | -2.48 | -2.78 | -2.56 | -2.31 | -2.37 | -1.87 | -1.79 | -1.91 | -1.64 | -1.71 | -1.68 | -0.94 | -0.96 | -0.90 | -0.86 | -0.75 | -0.70 | -0.72 | |
| – | – | – | 1.28 | 1.50 | 1.73 | 1.22 | 2.52 | 1.39 | 1.40 | 1.21 | 1.26 | 1.41 | 1.69 | 1.85 | 2.03 | 2.19 | 2.38 | 2.28 | 2.16 | 2.35 | 2.12 | 2.17 | 2.39 | 2.57 | 2.63 | 2.78 | 1.73 | 1.57 | 1.66 | 1.70 | 1.55 | 1.41 | 1.39 | |
| 10.79 | – | -21.25 | -21.25 | -2.11 | -1.34 | -15.07 | 5.05 | 2.12 | 5.54 | 3.91 | 3.40 | 2.89 | 2.42 | 1.91 | 1.39 | 0.69 | -0.11 | 1.39 | 0.75 | 0.16 | 1.72 | 1.25 | 0.77 | 0.59 | 0.12 | -0.25 | 0.71 | 0.40 | 0.20 | 0.03 | 0.12 | -0.09 | -0.28 | |
| – | – | – | -3.31 | -3.76 | -3.73 | -2.66 | -4.61 | -2.39 | -2.48 | -1.71 | -1.71 | -1.79 | -1.74 | -1.96 | -2.14 | -2.28 | -2.71 | -2.41 | -2.22 | -2.27 | -1.85 | -1.73 | -1.69 | -1.81 | -1.79 | -1.86 | -1.06 | -0.83 | -0.76 | -0.69 | -0.55 | -0.53 | -0.55 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.